Sign in

CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company

Neumora Therapeutics, Inc.

Sign in to watch
Ticker
NMRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
844367680
Phone
(857) 760-0900
Business address
260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. CERT Other Certification
  9. 8-A12B Other Registration of Securities
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. S-1/A Offering Registration Statement
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. S-1 Offering Registration Statement
  15. UPLOAD Other SEC-generated Letter
  16. DRS/A Other Draft Registration Statement
  17. DRSLTR Other Correspondence Related to Draft Registration Statement
  18. UPLOAD Other SEC-generated Letter
  19. DRSLTR Other Correspondence Related to Draft Registration Statement
  20. DRS/A Other Draft Registration Statement

Page 12 of 13 · 258 filings